Reports for ELVIUM LIFE SCIENCES
Company Name
ELVIUM LIFE SCIENCES
Totals |
||
Shortage reports |
129 |
|
| Actual shortage: | 1 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 2 (2%) | |
| Resolved: | 126 (98%) | |
Discontinuation Reports |
1 |
|
| To be discontinued: | 1 (100%) | |
| Discontinued: | 0 (0%) | |
| Reversed: | 0 (0%) | |
Late reports |
1 (1%) |
|
Overdue reports |
1 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2021-12-22 | 2022-01-27 | 151794 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-03-02 | 2022-04-23 | 155891 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-05-12 | 2022-07-26 | 160483 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-08-03 | 2022-09-17 | 165918 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-09-30 | 2022-10-22 | 170536 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-12-02 | 2023-01-09 | 176978 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-02-03 | 2023-02-17 | 183533 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-04-05 | 2023-04-19 | 188877 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Avoided shortage | 2023-06-28 | 2023-06-28 | 196767 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-07-21 | 2023-08-28 | 199441 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-09-07 | 2023-09-23 | 203858 |
| FOQUEST | 100MG | CAPSULE (CONTROLLED RELEASE) | Actual shortage | 2021-12-22 | 2024-03-06 | 151791 |
| TIMOPTIC | 0.5% | SOLUTION | Resolved | 2019-12-20 | 2020-08-19 | 101859 |
| TIMOPTIC | 0.5% | SOLUTION | Resolved | 2020-09-28 | 2020-10-27 | 125182 |
| TIMOPTIC | 0.5% | SOLUTION | Resolved | 2020-11-20 | 2020-12-10 | 128672 |
| TIMOPTIC-XE | 0.5% | SOLUTION (EXTENDED RELEASE) | Resolved | 2020-01-15 | 2020-06-19 | 103337 |
| TIMOPTIC-XE | 0.5% | SOLUTION (EXTENDED RELEASE) | Resolved | 2020-07-20 | 2020-07-28 | 120668 |
| TIMOPTIC-XE | 0.5% | SOLUTION (EXTENDED RELEASE) | Resolved | 2020-08-10 | 2020-10-03 | 121996 |
| TIMOPTIC-XE | 0.5% | SOLUTION (EXTENDED RELEASE) | Resolved | 2024-04-02 | 2024-04-17 | 224103 |
| TRUSOPT | 2% | SOLUTION | Resolved | 2022-04-15 | 2022-04-23 | 158916 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| UNIPHYL | 400MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2021-02-01 | 2021-02-01 | 133063 |
Showing 1 to 1 of 1